Investigators assessed a large population of Italian patients with resistant multiple sclerosis spasticity treated with THC:CBD to determine real-life, long-term efficacy outcomes. PHILADELPHIA — Real ...

Oral spray containing two compounds derived from the cannabis plant reduced spasticity compared with placebo in patients already taking anti-spasticity drugs. Oral spray containing two compounds ...

A combination of delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) relieved certain neurophysiological symptoms affecting patients with secondary progressive multiple sclerosis (MS). Oral spray ...

Treatment with the cannabis-based oral spray Nabiximols has been found to significantly relieve spasticity, a common symptom of multiple sclerosis (MS), according to a new analysis of two MS clinical ...

Cannabis compounds given through oral spray decreased spasticity more when compared to the placebo in patients already taking anti-spasticity drugs for motor neuron disease. Chemical compounds derived ...

Per the authors, at the time of manuscript writing, 30 states and the District of Columbia had passed laws legalizing cannabis in some form, with 9 states allowing the recreational use of cannabis.

CBD (cannabidiol) and THC (tetrahydrocannabinol) are two of the most well-known compounds found in the cannabis plant. While they share a common origin, their effects on the human body are quite ...

Oral spray containing two compounds derived from the cannabis plant reduced spasticity compared with placebo in patients already taking anti-spasticity drugs. Chemical compounds derived from the ...